Treatment with continuous infusion of intraduodenal (Duodopa®) levodopa / carbidopa is indicated in patients with advanced Parkinson's disease who have not responded to conventional treatment. We present here the case of a patient with this type of probe that debuted jejunitis. A distal phytobezoar was the main causal agent. This rare complication may be favored in cases of intestinal hypomotility. Treatment involves its withdrawal as soon as possible and replacement by a new probe, which results in healing.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
jejunitis secondary
4
secondary duodopa®
4
duodopa® probe
4
probe complication
4
complication treatment
4
treatment continuous
4
continuous infusion
4
infusion intraduodenal
4
intraduodenal duodopa®
4
duodopa® levodopa
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!